Clinical Trials Sponsored by Incyte Corporation
Total 6554 results
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedSquamous Cell Carcinoma of Anal CanalSpain, United Kingdom, United States, Germany, Belgium, France, Denmark, Italy, Norway
-
Incyte CorporationNo longer available
-
Incyte CorporationCompletedHidradenitis SuppurativaUnited States
-
Incyte CorporationCompletedAdvanced MalignanciesUnited States
-
Incyte CorporationWithdrawnMarginal Zone Lymphoma (MZL) | Follicular Lymphoma ( FL)
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
Incyte CorporationTerminatedAdvanced or Metastatic Solid Tumors | FGFR Mutations | FGFR TranslocationsUnited States
-
Incyte CorporationCompletedLymphomaUnited States, Spain, Korea, Republic of, Belgium, Australia, Czechia, Poland, Canada, France, Italy, United Kingdom
-
Incyte CorporationTerminated
-
Incyte CorporationCompleted
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States, United Kingdom, Spain
-
Incyte CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Incyte CorporationTerminated
-
Incyte CorporationWithdrawnAdvanced and/or Metastatic Solid Tumors | Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer | Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States
-
Incyte CorporationWithdrawnModerate to Severe Ulcerative Colitis
-
Incyte CorporationTerminatedMyeloproliferative Neoplasm (MPN)United States, Italy
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States
-
Incyte CorporationNo longer available
-
Incyte CorporationNo longer available
-
Incyte CorporationCompletedPlaque PsoriasisUnited States, Canada
-
Incyte CorporationTerminatedOvarian Cancer | Genitourinary (GU) TumorsUkraine, United Kingdom, United States, Australia, Canada, Russian Federation
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Incyte CorporationCompletedRheumatoid ArthritisUnited States, Czechia
-
Incyte CorporationCompletedHIV InfectionsUnited States
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Canada, Australia
-
Incyte CorporationCompletedPolycythemia Vera | Thrombocytosis | MyelofibrosisUnited States
-
Incyte CorporationTerminatedCRC (Colorectal Cancer)United States, France, United Kingdom, Spain, Israel, Australia, Germany, Korea, Democratic People's Republic of
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Incyte CorporationTerminatedPancreatic Cancer | Solid TumorsUnited States
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Incyte CorporationTerminatedMDS (Myelodysplastic Syndrome)United States
-
Incyte CorporationCompletedObesity | Diabetes Mellitus, Type 2United States
-
Incyte CorporationCompletedRheumatoid ArthritisUnited States, Poland
-
Incyte CorporationTerminatedType 2 DiabetesUnited States
-
Incyte CorporationNot yet recruiting
-
Incyte CorporationRecruiting
-
Incyte CorporationRecruiting
-
Incyte CorporationNot yet recruitingMyeloproliferative Neoplasms
-
Incyte CorporationRecruitingAtopic DermatitisGermany, Poland, United States, Spain, United Kingdom, Italy, Belgium, Canada, Netherlands, Australia, Bulgaria, France, Switzerland, Hungary, Korea, Republic of
-
Incyte CorporationRecruitingPrurigo NodularisUnited States
-
Incyte CorporationRecruitingSolid TumorsUnited States, France, Italy, Australia, Spain, Canada, Belgium
-
Incyte CorporationRecruitingNonSegmental VitiligoSpain, Japan, United States, Poland, Canada, Belgium, Germany, Netherlands, France, Mexico